EGFR and laryngotracheoesophageal cleft: Taxane-containing chemotherapy, ﻿targeted therapies such as epidermal growth factor receptor (EGFR)-﻿tyrosine kinase inhibitors (TKIs), and immune checkpoint inhibitors (ICIs) are common causes of drug-induced ILDs during systemic LC therapies [14–16].